Nautilus Biotechnology to Participate in the TD Cowen 46th Annual Health Care Conference
Thursday, February 19, 2026 1 min read
Key Takeaway: Nautilus Biotechnology, Inc. has announced its participation in the TD Cowen 46th Annual Health Care Conference, scheduled for March 2, 2026. During the event, Nautilus management will engage in a fireside chat, which can be accessed live and archived on the company's website. Nautilus is focused on revolutionizing the field of proteomics through its innovative platform technology, aiming to enhance understanding and access to the proteome.
Market Sentiment Analysis
POSITIVE FACTORS
Nautilus Biotechnology is participating in a prominent health care conference.
The company is pioneering a unique single-molecule protein analysis platform.
The event provides an opportunity for broader visibility and engagement with investors.
Full Press Release Details
SEATTLE, Feb. 19, 2026 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single-molecule protein analysis platform, today announced the company will be participating in the TD Cowen 46th Annual Health Care Conference.
Nautilus’ management is scheduled to participate in a fireside chat on Monday, March 2, 2026, at 10:30 a.m. Eastern Time. Interested parties may access a live and archived webcast of the presentation on the “Investors” section of the company website at: www.nautilus.bio.
About Nautilus Biotechnology, Inc.
With its corporate headquarters in Seattle, Washington and its research and development headquarters in San Carlos, California, Nautilus is a development stage life sciences company working to create a platform technology for quantifying and unlocking the complexity of the proteome. Nautilus’ mission is to transform the field of proteomics by democratizing access to the proteome and enabling fundamental advancements across human health and medicine. To learn more about Nautilus, visit www.nautilus.bio.